Oscar Health Inc. (NYSE:OSCR) shares traded -8.24% lower at $7.57 on Wall Street last session.
In accordance with the data, 6 analysts cover Oscar Health Inc. (NYSE:OSCR). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $12.00 and a low of $5.50, we find $7.88. Given the previous closing price of $8.25, this indicates a potential downside of -4.48 percent. OSCR stock price is now -3.31% away from the 50-day moving average and 52.96% away from the 200-day moving average. The market capitalization of the company currently stands at $1.64B.
It has been rated a hold by 4 analysts and a buy by 2. Brokers who have rated the stock have averaged $8.21 as their price target over the next twelve months.
With the price target enhanced from $5.40 to $8.75, BofA Securities Upgraded its rating from Underperform to Neutral for Oscar Health Inc. (NYSE: OSCR).
In other news, Blackley Richard Scott, Chief Transformation Officer sold 23,955 shares of the company’s stock on Jun 06. The stock was sold for $201,093 at an average price of $8.39. Upon completion of the transaction, the Chief Transformation Officer now directly owns 437,975 shares in the company, valued at $3.32 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 06, EVP, Chief Insurance Officer Quane Alessandrea C. sold 11,859 shares of the business’s stock. A total of $99,552 was realized by selling the stock at an average price of $8.39. This leaves the insider owning 232,789 shares of the company worth $1.76 million. Insiders disposed of 533,645 shares of company stock worth roughly $4.04 million over the past 1 year. A total of 0.40% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in OSCR stock. A new stake in Oscar Health Inc. shares was purchased by BALYASNY ASSET MANAGEMENT L.P. during the first quarter worth $15,452,000. WOODLINE PARTNERS LP invested $9,634,000 in shares of OSCR during the first quarter. In the first quarter, GILDER GAGNON HOWE & CO LLC acquired a new stake in Oscar Health Inc. valued at approximately $7,152,000. KINGDON CAPITAL MANAGEMENT, L.L.C. acquired a new stake in OSCR for approximately $6,813,000. BANK OF MONTREAL /CAN/ purchased a new stake in OSCR valued at around $2,778,000 in the second quarter. In total, there are 188 active investors with 88.30% ownership of the company’s stock.
Oscar Health Inc. (NYSE: OSCR) opened at $8.40 on Wednesday. During the past 12 months, Oscar Health Inc. has had a low of $2.05 and a high of $9.89. The fifty day moving average price for OSCR is $7.85 and a two-hundred day moving average price translates $4.96 for the stock.
The latest earnings results from Oscar Health Inc. (NYSE: OSCR) was released for Mar, 2023. According to the Healthcare Plans Company, earnings per share came in at -$0.18, missing analysts’ expectations of -$0.05 by -0.13. This compares to -$0.36 EPS in the same period last year. The net profit margin was -12.80% and return on equity was -55.10% for OSCR. The company reported revenue of $1.47 billion for the quarter, compared to $972.76 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 51.08 percent. For the current quarter, analysts expect OSCR to generate $1.44B in revenue.
Oscar Health Inc.(OSCR) Company Profile
Oscar Health, Inc. operates as a health insurance in the United States. The company offers Individual and Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payors directly enable their shift to value-based care It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
